Credibility in this field is earned in orbit. We prove the platform on our own demonstrator before we ask a partner to trust it with theirs — the same path the field's pioneers took.
Advisory network built across eight universities. Preliminary pharmaceutical studies completed, including molecule selection. First conversations with pharmaceutical companies. Selected by ESA BIC Milan for its incubation programme.
Detailed feasibility studies and preliminary module design produce a firm engineering plan. ESA BIC milestones delivered; European public-funding applications advanced. A dedicated PhD programme on module design and its digital twin starts at Politecnico di Milano.
Core team hired, laboratory stood up. We build and qualify our first modules — the ground reference and the flight demonstrator — and fly our own molecule on a small autonomous satellite. Results are published: "possible in theory" becomes "proven, and European".
With the demonstrator flown and published, a pharmaceutical partner signs and we crystallise their molecule in orbit with the second-generation modules — the first mission flown on a client programme.
We design, build and fly the recovery-class Module Gamma inside a cargo-return capsule, complete GMP certification, and deliver the first kilogram-scale batch of orbitally crystallised drug substance to our partner — opening recurring commercial supply.
Dates are indicative.
Write to info [at] zerogravityworks [dot] com